Literature DB >> 20072998

S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII).

W Schmiegel1, C Pox, A Reinacher-Schick, G Adler, D Arnold, W Fleig, U R Fölsch, P Frühmorgen, U Graeven, V Heinemann, W Hohenberger, A Holstege, T Junginger, I Kopp, T Kühlbacher, R Porschen, P Propping, J-F Riemann, C Rödel, R Sauer, T Sauerbruch, W Schmitt, H-J Schmoll, T Seufferlein, M Zeitz, H-K Selbmann.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20072998     DOI: 10.1055/s-0028-1109936

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


× No keyword cloud information.
  44 in total

1.  Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols.

Authors:  Ute Günther; Dajana Kusch; Frank Heller; Nataly Bürgel; Silke Leonhardt; Severin Daum; Britta Siegmund; Christoph Loddenkemper; Maria Grünbaum; Heinz-Johannes Buhr; Jörg-Dieter Schulzke; Martin Zeitz; Christian Bojarski
Journal:  Int J Colorectal Dis       Date:  2011-01-29       Impact factor: 2.571

2.  Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer. Treatment outcome outside clinical trials.

Authors:  J Winkler; L Zipp; J Knoblich; F Zimmermann
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

3.  [Staging of rectal cancer].

Authors:  C T Germer
Journal:  Chirurg       Date:  2012-05       Impact factor: 0.955

4.  How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.

Authors:  Ulrike Haug; Amy B Knudsen; Karen M Kuntz
Journal:  Int J Cancer       Date:  2012-03-29       Impact factor: 7.396

5.  Chemo-Radiation After Upfront Rectal Resections-a Clinical Dilemma.

Authors:  A Saklani; P Sugoor; M Bhandare; S Jatal; A Desouza; V Ostwal
Journal:  Indian J Surg Oncol       Date:  2018-08-18

6.  New methods for clinical pathways-Business Process Modeling Notation (BPMN) and Tangible Business Process Modeling (t.BPM).

Authors:  Hubert Scheuerlein; Falk Rauchfuss; Yves Dittmar; Rüdiger Molle; Torsten Lehmann; Nicole Pienkos; Utz Settmacher
Journal:  Langenbecks Arch Surg       Date:  2012-02-24       Impact factor: 3.445

Review 7.  Lynch syndrome: clinical, pathological, and genetic insights.

Authors:  Ralph Schneider; Claudia Schneider; Matthias Kloor; Alois Fürst; Gabriela Möslein
Journal:  Langenbecks Arch Surg       Date:  2012-02-24       Impact factor: 3.445

8.  [Local control in T3 rectal cancer : short-course radiotherapy versus chemoradiation].

Authors:  C Rödel; G Klautke
Journal:  Strahlenther Onkol       Date:  2013-02       Impact factor: 3.621

Review 9.  Surgical intervention for pulmonary metastases.

Authors:  Joachim Pfannschmidt; Gerlinde Egerer; Marc Bischof; Michael Thomas; Hendrik Dienemann
Journal:  Dtsch Arztebl Int       Date:  2012-10-05       Impact factor: 5.594

10.  [Training course transanal total mesorectal excision (TaTME) : Concept and establishment of a training course for safe application].

Authors:  F Aigner; M Biebl; A Fürst; T Jöns; J Pratschke; W Kneist
Journal:  Chirurg       Date:  2017-02       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.